Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
DermAll nanomedicine for allergen-specific immunotherapy.
Garaczi E, Szabó K, Francziszti L, Csiszovszki Z, Lőrincz O, Tőke ER, Molnár L, Bitai T, Jánossy T, Bata-Csörgő Z, Kemény L, Lisziewicz J. Garaczi E, et al. Among authors: csiszovszki z. Nanomedicine. 2013 Nov;9(8):1245-54. doi: 10.1016/j.nano.2013.05.011. Epub 2013 Jun 6. Nanomedicine. 2013. PMID: 23747740
Exploitation of Langerhans cells for in vivo DNA vaccine delivery into the lymph nodes.
Tőke ER, Lőrincz O, Csiszovszki Z, Somogyi E, Felföldi G, Molnár L, Szipőcs R, Kolonics A, Malissen B, Lori F, Trocio J, Bakare N, Horkay F, Romani N, Tripp CH, Stoitzner P, Lisziewicz J. Tőke ER, et al. Among authors: csiszovszki z. Gene Ther. 2014 Jun;21(6):566-74. doi: 10.1038/gt.2014.29. Epub 2014 Apr 3. Gene Ther. 2014. PMID: 24694539 Free PMC article.
A Peptide Vaccine Candidate Tailored to Individuals' Genetics Mimics the Multi-Targeted T Cell Immunity of COVID-19 Convalescent Subjects.
Somogyi E, Csiszovszki Z, Molnár L, Lőrincz O, Tóth J, Pattijn S, Schockaert J, Mazy A, Miklós I, Pántya K, Páles P, Tőke ER. Somogyi E, et al. Among authors: csiszovszki z. Front Genet. 2021 Jun 23;12:684152. doi: 10.3389/fgene.2021.684152. eCollection 2021. Front Genet. 2021. PMID: 34249101 Free PMC article.
In Silico Model Estimates the Clinical Trial Outcome of Cancer Vaccines.
Lőrincz O, Tóth J, Molnár L, Miklós I, Pántya K, Megyesi M, Somogyi E, Csiszovszki Z, Tőke ER. Lőrincz O, et al. Among authors: csiszovszki z. Cells. 2021 Nov 5;10(11):3048. doi: 10.3390/cells10113048. Cells. 2021. PMID: 34831269 Free PMC article.
Safety and Activity of PolyPEPI1018 Combined with Maintenance Therapy in Metastatic Colorectal Cancer: an Open-Label, Multicenter, Phase Ib Study.
Hubbard JM, Tőke ER, Moretto R, Graham RP, Youssoufian H, Lőrincz O, Molnár L, Csiszovszki Z, Mitchell JL, Wessling J, Tóth J, Cremolini C. Hubbard JM, et al. Among authors: csiszovszki z. Clin Cancer Res. 2022 Jul 1;28(13):2818-2829. doi: 10.1158/1078-0432.CCR-22-0112. Clin Cancer Res. 2022. PMID: 35472243 Free PMC article. Clinical Trial.
T cell immunity ameliorates COVID-19 disease severity and provides post-exposure prophylaxis after peptide-vaccination, in Syrian hamsters.
Somogyi E, Kremlitzka M, Csiszovszki Z, Molnár L, Lőrincz O, Tóth J, de Waal L, Pattijn S, Reineking W, Beineke A, Tőke ER. Somogyi E, et al. Among authors: csiszovszki z. Front Immunol. 2023 Jan 24;14:1111629. doi: 10.3389/fimmu.2023.1111629. eCollection 2023. Front Immunol. 2023. PMID: 36761759 Free PMC article.
18 results